{"id":"W4221036645","doi":"10.1097/qad.0000000000003218","title":"Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates","year":2022,"lang":"en","type":"article","venue":"AIDS","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Group B; In vitro; Group A; Group (periodic table); Multiple drug resistance; Antibacterial agent","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005100126,0.000130346,0.000274423,0.0001038006,0.0002551779,0.00001323982,0.0001525912,0.0001035645,0.0006536903],"category_scores_gemma":[0.0000540644,0.0001154943,0.0000883973,0.0001345415,0.0001809243,0.00007557887,0.0003531447,0.0005741872,0.0002417713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007731483,"about_ca_system_score_gemma":0.00003723813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001503598,"about_ca_topic_score_gemma":0.00006036059,"domain_scores_codex":[0.9983409,0.000667924,0.0002031758,0.0003507448,0.00003994239,0.0003972804],"domain_scores_gemma":[0.9993669,0.0003102179,0.00004435666,0.0002272756,0.000008342127,0.000042934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003337091,0.002410696,0.2171263,0.00002017459,0.0005051037,0.0002354348,0.0004546589,0.00000161942,0.3800243,0.0006670953,0.006910243,0.3883073],"study_design_scores_gemma":[0.03175755,0.01078632,0.4359472,0.00003314708,0.0001459377,0.0003894517,0.001565427,0.0001398929,0.02487531,0.001043586,0.4921449,0.001171269],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957912,0.0019442,0.00003411682,0.0002308096,0.0002239486,0.0002362567,0.0001971666,0.00004028747,0.001301993],"genre_scores_gemma":[0.9980072,0.000155764,0.00008724999,0.000205654,0.00001937534,0.0001169615,0.0003023127,0.0000121885,0.001093285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4852347,"threshold_uncertainty_score":0.715745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02333816314005701,"score_gpt":0.2964773441019996,"score_spread":0.2731391809619426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}